The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
You must be an absolute moron. Manchester trust is the most advanced GDR dialogue and they are spending 1.2m to gather data and test etc etc via devote. If you think there will be a contact anywhere within the NHS then you are just deluded or purposely being stupid. As roger says its years away. You aint getting a contract until the data gathering and samples.are done to death pal
Good old Watching. Always turns up when a share is down to feign interest but when a share like Avacta starts doing well he has nothing left to say. I think he searches out weak shares to talk shyte..as soon as this turns he'll foff. I'll save him the bother and filter .
I'll get off the soapbox shortly but to say that the way to sell AIHL is to weaponise all the parents that have needlessly had their children lose their hearing. Once its political, things will actually move. Its a disgrace that we have deaf kids out there unnecessarily and THAT is the whole point. Not chasing deals but laying at the Trusts door that its wholly unacceptable. I'd go far to say that you could fish out some parents and get them to go legal on this.
SystemZ fair enough..my issue with the stroke marker is that at the last raise it wasn't fully subscribed and there wasn't enough for further R&D. The market effectively said " commercialise what you've got before opening up other lines" - the stroke marker would be behind the AIHL development and still facing the same sales cycle into the NHS?? All the eggs are in that basket. For that trial to have successfully happened over 2 years ago and for Data needs to still be required etc, strikes me as a near impossible task to circumvent the NHS machine. Its actually shameful in a world of AI, Robotics, Simulations, Data models etc. You can replicate all of this with Data science on existing Data, so its just a barrier that doesn't need to be there.
Is randomly guessing the SP day to day worthy of posting SystemZero? The question that you need to ask yourself is how and when can GDR get to break-even?......
.....In August 2021 The FT posted this: A large-scale implementation trial of the Genedrive® MT-RNR1 assay was performed on 750 newborns by Manchester and Liverpool Hospitals and concluded in November 2020. The trial represented the world's first use of a genetic point of care test in a Neonatal Intensive Care (NICU) setting. The results of this innovative trial have now been submitted by the study team for publication. Extensive feedback was taken from over 150 nurses who performed AIHL testing over the trial period and this has resulted in a number of refinements being made to the Genedrive® unit design principally to further enhance usability in a NICU setting. So far Sales remains at Zero.
How can anyone possibly want to invest in a business that is clearly pushing against the door of a broken institution. The NHS is the most undynamic organisation incapable of any commerciality. The whole UK market is only worth 5M a year and the GDR cash burn rate would need close to full saturation to turn a profit! Its staring you in plain sight that the model doesn't work. Someone needs to buy the kit and invest long term, but you'll only get a goodwill offer for the tech of a few pennies as there is no income/revenue. The new CEO will broker that deal and get a nice LT sweetner to make it happen. Is not just blindingly obvious to everyone???
Ghanian political culture is slowly shifting. Huge debt IMF bailouts and all from corruption and very inefficient state owned companies. The new reality is that they need to produce more and are learning that you cant just screw corporates into the ground. No point guessing how long that ll take for them to change their mindset but it won t be forever. It might nkt ne next year either!
Yawwwwwwwwnnnn. Sorry I'm just writing an executive summary on the GDR posts.
More utter delusion here. All the holders blaming Budd. Do you think any CEO would have somehow done any better then??? Really? The answer is a resounding 'No'. Unless you think someone out there can circumvent the NHS apparatus, Buying committees, procurement processes, layers of decision makers and all the structures in place? This is the reality of selling something Novel into the NHS sadly. It takes years. I said back in 2021 this would be a 3-5 year journey and that the short term funding doesn't fit with the long term needs of the business. Now here we are. The mistake Budd made wasn't sales, it was not selling the business when approached. He thought he'd hold out for a better personal deal despite no cashflow, under the belief he'd get a higher multiple for GDR. Well that was silly as it generates little if any cash, so he should have taken the deal at circa 30p per share. The new CEO will sell up and is why he is there.
The bottom has been 1.20, 1, 80p, 50p ..good luck with that falling knife
The level of delusion on this board is staggering. I have no agenda here. Surely it was blindingly obvious this was going to dive south on the incoming weak news?? And surely its blindingly obvious that this is only going one way. Let's be clear. The damage wrought by interest rates is only just starting. If you want to believe the narrative about wages catching up with inflation, then be my guest. This will go sub 20p. Massive and urgent rationalisation of the business needed fast. Back to the bare bones before its forced and not voluntary.
I think I just saw Ed Harris go past??? (ref The Abyss lol)
You don't like Roger's narrative which is worrying. 1. you're far too emotive and "attached" to your investment which means you probably can't afford to lose your investment. 2. He's hitting home with some uncomfortable truths which you want to brush off like he's entirely wrong.
Any balanced person would take Rogers perspective and though you may not agree it isn't baseless, so ignore or bury your head in the sand at your own peril.
This is an Aim business that doesn't generate revenue and by its very nature is high risk. Your capital is at risk and CEO's are prone to telling fibs on AIM for their own betterment. That fact sir, is entirely irrefutable and might help you to think big picture rather than the minutae which may or may not be grounded in reality.
The people selling it down are the same ones buying it back. Most in this are at 0.012-00.15 and long
tbf i've not seen 1 single ramp on this board??? i think its ok to state that if the trial goes well and the long dialogue with bolivia bears fruit that this will multi-bag. do you think if that happens the sp will be static watching?? any commentary here is stated on an "if" basis not materially "guaranteed to happen" basis. i think you're flavouring the board to be antagonistic and are possibly a prize ****?
None of that will happen cos people won t stand for it. Unless they sit here like you commentating on the sidelines and accepting it.
The new guy has no shares in the business. That already implies some major refunding so the new C-suite guys can take a meaningful participation. Mass dilution on the cards = 1-2 years of waiting for the price to reinflate from whatever god awful base the raise happens at. You will at least get a clear view on the plan and timelines come Q1 2024.
Beautifully put Basher.
The thing that has change is the vulnerability of NextChem but I wager they are banking on a positive result to then get funding. Its a bit eye of the needle stuff here and risky. My average is about 13.5 here but I wont load up more personally. I've seen lots of folk "average down" which also means the market is loading up the risk on RI's. That so often ends up being a disaster. Truth is this is a multibagger at any price and for everyone IF it works out. IF. I'd say there is a good chance it will.
You are niaive. This company will without a shadow of doubt become a major success but it will be recapitalised, under different managment and likely with new owners share holders etc. If you think it ll serenely chug along without major ructures then more fool you
As previously stated- why take a business over until its on its knees? Doesnt work that way. You ll get a pittance.
TbF there s plenty of confidence in it. It is entirely novel, unknown and unproven and doesn t fit 99% of the investment profile of fund mgrs or the wider investment community who like things called dividends in the main. I mean what are you expecting exactly????